DigicitrinCAS# 5065-10-1 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 5065-10-1 | SDF | Download SDF |
| PubChem ID | 10071564 | Appearance | Yellow powder |
| Formula | C21H22O10 | M.Wt | 434.4 |
| Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 5-hydroxy-2-(3-hydroxy-4,5-dimethoxyphenyl)-3,6,7,8-tetramethoxychromen-4-one | ||
| SMILES | COC1=CC(=CC(=C1OC)O)C2=C(C(=O)C3=C(C(=C(C(=C3O2)OC)OC)OC)O)OC | ||
| Standard InChIKey | GIEYELPGDHOPHM-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C21H22O10/c1-25-11-8-9(7-10(22)16(11)26-2)15-18(27-3)13(23)12-14(24)19(28-4)21(30-6)20(29-5)17(12)31-15/h7-8,22,24H,1-6H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Digicitrin Dilution Calculator
Digicitrin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.302 mL | 11.5101 mL | 23.0203 mL | 46.0405 mL | 57.5506 mL |
| 5 mM | 0.4604 mL | 2.302 mL | 4.6041 mL | 9.2081 mL | 11.5101 mL |
| 10 mM | 0.2302 mL | 1.151 mL | 2.302 mL | 4.6041 mL | 5.7551 mL |
| 50 mM | 0.046 mL | 0.2302 mL | 0.4604 mL | 0.9208 mL | 1.151 mL |
| 100 mM | 0.023 mL | 0.1151 mL | 0.2302 mL | 0.4604 mL | 0.5755 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 1-(3,4,5-Trihydroxypentanoyl)-β-carboline
Catalog No.:BCN0606
CAS No.:180995-40-8
- 7-(6'R-hydroxy-3',7'-dimethylocta-2',7'-dienyloxy)coumarin
Catalog No.:BCN0605
CAS No.:118584-19-3
- (8R,12R,13R)-8,12-Epoxylabd-14-en-13-ol
Catalog No.:BCN0604
CAS No.:56682-25-8
- Forsythide dimethyl ester
Catalog No.:BCN0603
CAS No.:42830-22-8
- 7-Hydroxy-1-methoxy-3-methylcarbazole
Catalog No.:BCN0602
CAS No.:107672-54-8
- 3,7,8-Tri-O-methylellagic acid 2-O-rutinoside
Catalog No.:BCN0601
CAS No.:56470-18-9
- cis-Vitisin B
Catalog No.:BCN0600
CAS No.:142507-86-6
- Taraxinic acid β-D-glucopyranosyl ester
Catalog No.:BCN0599
CAS No.:75911-14-7
- 11β,13-Dihydrotaraxinic acid β-D-glucopyranosyl ester
Catalog No.:BCN0598
CAS No.:75911-16-9
- 3-Hydroxy-4-methoxybenzyl alcohol
Catalog No.:BCN0597
CAS No.:4383-06-6
- 3β,7β-Dihydroxy-25-methoxycucurbita-5,23-dien-19-al
Catalog No.:BCN0596
CAS No.:132587-67-8
- 8-[(6,7-Dihydroxy-3,7-dimethyloct-2-en-1-yl)oxy]psoralen
Catalog No.:BCN0595
CAS No.:889112-17-8
- 4-Allyl-2,6-dimethoxyphenyl glucoside
Catalog No.:BCN0608
CAS No.:100187-70-0
- Flaccidinin
Catalog No.:BCN0609
CAS No.:121817-23-0
- erythro-1-(4-Hydroxyphenyl)propane-1,2,3-triol
Catalog No.:BCN0610
CAS No.:25743-67-3
- 1,6,2',3',6'-O-Pentaacetyl-3-O-trans-p-coumaroylsucrose
Catalog No.:BCN0611
CAS No.:138213-63-5
- (S)-(-)-2-Amino-3-methyl-1,1-diphenyl-1-butanol
Catalog No.:BCN0612
CAS No.:78606-95-9
- 1,1'-[1,4-Phenylenebis(methylene)]bis[4,8,11-tris[(4-methylphenyl)sulfonyl]-1,4,8,11-tetraazacyclotetradecane
Catalog No.:BCN0613
CAS No.:110078-47-2
- Aristolactam IIIa N-β-glucoside
Catalog No.:BCN0614
CAS No.:80311-26-8
- 2-Ethyl-3-methylmaleimide N-β-D-glucopyranoside
Catalog No.:BCN0615
CAS No.:182228-46-2
- Thalmineline
Catalog No.:BCN0616
CAS No.:28328-00-9
- 16-Oxolyclanitin-29-yl p-coumarate
Catalog No.:BCN0617
CAS No.:140701-70-8
- 6″-O-Acetylsaikosaponin b3
Catalog No.:BCN0618
CAS No.:104109-34-4
- threo-1-(4-Hydroxyphenyl)propane-1,2,3-triol
Catalog No.:BCN0619
CAS No.:155748-73-5
[Serum metabolomics of preterm and full-term infants based on gas chromatography-mass spectrometry].[Pubmed:30907351]
Zhongguo Dang Dai Er Ke Za Zhi. 2019 Mar;21(3):259-264.
OBJECTIVE: To study the features of serum metabolites in preterm infants based on gas chromatography-mass spectrometry (GC-MS), and to find differentially expressed metabolites in the serum of preterm infants. METHODS: Serum samples were collected from 19 preterm infants and 20 full-term infants before feeding. GC-MS was used to measure metabolic profiles, and the metabolic features of 397 serum metabolites in preterm infants were analyzed. RESULTS: There was a significant difference in serum metabolic features between the preterm and full-term infants before feeding. There were significant differences between the full-term and preterm infants in the levels of metabolites such as O-phosphonothreonine, Digicitrin, tannic acid, and fructose-1,6-diphosphate (P<0.01), suggesting that the above differentially expressed metabolites were highly differentiated between the preterm and full-term infants. Most differentially expressed metabolites were involved in the metabolic pathways such as ABC transporters, beta-alanine and pyrimidines and were correlated with some clinical parameters (albumin and total bilirubin) (P<0.05). CONCLUSIONS: There is a significant difference in serum metabolites between preterm and full-term infants before feeding. Metabolomics plays an important role in improving metabolic disorders and exploring metabolism-related diseases in preterm infants.
Antimitotic and cytotoxic flavonols from Zieridium pseudobtusifolium and Acronychia porteri.[Pubmed:7964782]
J Nat Prod. 1994 Jul;57(7):1012-6.
Bioassay-guided fractionation of the extracts of Zieridium pseudobtusifolium and Acronychia porteri led to the isolation of 5,3'-dihydroxy-3,6,7,8,4'-pentamethoxyflavone [1], which showed activity against (KB) human nasopharyngeal carcinoma cells (IC50 0.04 micrograms/ml) and inhibited tubulin assembly into microtubules (IC50 12 microM). Two other known flavonols, Digicitrin [2] and 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone [5], were also isolated together with three new ones, 3-O-demethylDigicitrin [3], 3,5,3'-trihydroxy-6,7,8,4'-tetramethoxyflavone [4], and 3,5-dihydroxy-6,7,8,3',4'-pentamethoxyflavone [6]. All of these flavonols showed cytotoxic activity against KB cells.
